Showing results (271-280 of 291) with videos related to

Sort By:
Pageof 30
Pathologie (Heidelberg, Germany)|November 10, 2023
[Molecular diagnostics for vitreoretinal lymphoma]Irina Bonzheim, Julia Salmerón-Villalobos, Daniela Süsskind, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|July 7, 2020
Self-assembled DNA nanoparticles loaded with travoprost for glaucoma-treatmentSven Schnichels, José Hurst, Jan Willem de Vries, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|July 13, 2018
Retinal Toxicity of Medical Devices Used during Vitreoretinal Surgery: A Critical OverviewKai Januschowski, Cristina Irigoyen, J Carlos Pastor, et al.
Molecular Therapy. Oncology|July 23, 2024
Neoantigen-specific T cell help outperforms non-specific help in multi-antigen DNA vaccination against cancerJoanna Fréderique de Graaf, Tamara Pesic, Felicia S Spitzer, et al.
European Journal of Ophthalmology|May 5, 2021
The impact of vitrectomy on outcomes achieved with 0.19 mg fluocinolone acetonide implant in patients with diabetic macular edemaAlbert J Augustin, Silvia Bopp, Martin Fechner, et al.
Frontiers in Immunology|February 11, 2020
CD4 T Cell Determinants in West Nile Virus Disease and Asymptomatic InfectionMaximilian Koblischke, Felicia S Spitzer, David M Florian, et al.
Blood Advances|August 27, 2021
The molecular hallmarks of primary and secondary vitreoretinal lymphomaIrina Bonzheim, Philip Sander, Julia Salmerón-Villalobos, et al.
Plos One|June 16, 2026
Correction: Intravenous thrombolysis for acute central retinal artery occlusion: Protocol for a systematic review and individual participant data meta-analysis of randomized controlled trialsBrian Mac Grory, Cécile Preterre, Pierre Lebranchu, et al.
Plos One|March 10, 2026
Intravenous thrombolysis for acute central retinal artery occlusion: Protocol for a systematic review and individual participant data meta-analysis of randomized controlled trialsBrian Mac Grory, Cécile Preterre, Pierre Lebranchu, et al.
Frontiers in Medicine|December 2, 2020
Dynamics of CD4 T Cell and Antibody Responses in COVID-19 Patients With Different Disease SeverityMaximilian Koblischke, Marianna T Traugott, Iris Medits, et al.
Pageof 30